Rangeley Capital’s Kezar Life Sciences KZR Stock Holding History

Rangeley Capital’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-243,073	Closed	-$1.8M	–	197
2026 Q1	$1.8M	Buy	243,073 +157,147	+183%	+$1.02M	1.75%	19
2025 Q4	$540K	Buy	+85,926	New	+$501K	0.45%	49

Rangeley Capital's KZR Position: Q2 2026 in Review

Rangeley Capital sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 243,073 shares — an estimated $1.8M sold.

Rangeley Capital first reported a position in KZR in Q4 2025 and held it in 2 quarters. The position peaked at $1.8M in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

Rangeley Capital reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
Rangeley Capital sold 243,073 Kezar Life Sciences shares in Q2 2026, an estimated $1.8M.
Rangeley Capital first reported a position in Kezar Life Sciences in Q4 2025 and held it in 2 quarters.
Rangeley Capital's Kezar Life Sciences position peaked at $1.8M in Q1 2026.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.